The role of sphingosine 1-phosphate and its receptors in cardiovascular diseases

Area of Science:

• Biochemistry
• Cardiology
• Pharmacology

Background:

• Cardiovascular diseases (CVDs) present a significant global health and economic challenge.
• Sphingosine 1-phosphate (S1P) is a lipid mediator with diverse roles in cellular signaling.
• The precise involvement of S1P and its receptors (S1PRs) in CVD pathogenesis requires further elucidation.

Purpose of the Study:

• To review the synthesis, release, and functions of S1P.
• To detail the roles of S1P and S1PRs in common cardiovascular diseases.
• To discuss controversial aspects and explore S1P-based therapeutic developments for CVDs.

Main Methods:

• Literature review of S1P and S1PR functions in cardiovascular contexts.
• Analysis of S1P and S1PR roles in various cardiovascular diseases.
• Examination of current and emerging S1P-targeting therapies.

Main Results:

• S1P is essential in both normal physiology and disease states within the circulatory system.
• Evidence suggests complex and sometimes conflicting roles of S1P and S1PRs in cardiovascular pathogenesis.
• S1P receptor modulators, like amiselimod and fingolimod, show potential for cardiovascular therapeutics.

Conclusions:

• Elucidating the multifaceted roles of S1P and S1PRs is crucial for understanding cardiovascular disease.
• Targeting the S1P pathway presents promising avenues for novel cardiovascular disease treatments.
• Further research into S1P-based therapies could lead to improved patient outcomes in cardiology.